300223:SZSEIngenic Semiconductor Co., Ltd Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥124.36
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ingenic Semiconductor is trading at a steep premium, with a trailing P/E of 188x versus an industry average of 34x, and a DCF‑derived fair value of only ≈23 CNY compared to the current price of 124 CNY. The company’s fundamentals show modest revenue growth of 8.5%, thin operating margins (5.6%) and a low ROE of 2.5%, indicating limited earnings power to justify the valuation. On the technical side, the stock sits above its 20‑day and 50‑day SMAs, the trend is flagged as bullish, and volume is rising, yet the MACD has turned bearish and the RSI hovers around the neutral 50 level, suggesting short‑term momentum may be waning. Liquidity is strong with daily volumes well above the 10‑day average, and the beta of 0.23 points to muted market‑wide price swings, but the 30‑day volatility of nearly 80% signals pronounced intra‑period swings. The dividend yield is negligible at 0.08% and the payout ratio is low, making the dividend sustainable but not a meaningful return component. Overall, the stock’s price is driven more by market sentiment—reflected in an “Extreme Greed” fear‑greed index—than by underlying earnings prospects.
Given the stark disconnect between price and intrinsic value, investors should treat the stock as highly speculative. The semiconductor sector in China carries medium to high regulatory and geopolitical risk, and Ingenic’s modest cash generation may not offset the valuation gap. While the company’s cash balance is robust, the thin profitability and high valuation suggest a cautious stance, especially for longer horizons.
Given the stark disconnect between price and intrinsic value, investors should treat the stock as highly speculative. The semiconductor sector in China carries medium to high regulatory and geopolitical risk, and Ingenic’s modest cash generation may not offset the valuation gap. While the company’s cash balance is robust, the thin profitability and high valuation suggest a cautious stance, especially for longer horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages indicating bullish bias
- Bearish MACD crossover and neutral RSI suggesting weakening momentum
- Extreme overvaluation relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustained high valuation despite modest earnings growth
- Strong cash position but thin operating margins
- Sector cyclical risk and regulatory uncertainty in China
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Intrinsic value far below market price
- Low ROE and profit margins limiting long‑term earnings upside
- High sector volatility and geopolitical exposure
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin6.88%
P/E Ratio188.4
ROE2.50%
ROA0.85%
Debt/Equity0.17
P/B Ratio4.8
Op. Cash FlowCN¥656.2M
Free Cash FlowCN¥334.1M
Industry P/E34.2
Technical Analysis
TrendBullish
RSI49.7
SupportCN¥115.02
ResistanceCN¥144.50
MA 20CN¥125.49
MA 50CN¥125.22
MA 200CN¥89.82
MACDBearish
VolumeIncreasing
Fear & Greed Index79.57
Valuation
Fair ValueCN¥23.85
GradeOvervalued
TypeGrowth
Dividend Yield0.08%
Risk Assessment
Beta0.23
Volatility79.91%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.